Xilio Therapeutics, Inc.XLONASDAQ
Loading
Operating Margin Over TimeExpanding
Percentile Rank17
Studio
Year-over-Year Change

Operating income as a percentage of revenue

Latest
-137.64%
↑ 12% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-156.08%
Historical baseline
PeriodValueYoY Change
TTM-137.64%+85.6%
2024-954.95%-
20230.00%-
20220.00%-
20210.00%-
20200.00%-
20190.00%-